ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

NCI payline for investigator-initiated R01 grants falls to the 16th percentile, where it’s likely to stay in FY 2006 under the Bush Administration’s budget proposal.

March 25, 2005

In Washington: Health Groups Urge Congress: No Immunity For Tobacco Industry; Clinton Proposes $400M Effort To End Racial Health Disparities

February 27, 1998

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007